Gts Securities LLC Rhythm Pharmaceuticals, Inc. Call Options Transaction History

Gts Securities LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$35.41 - $44.37 $152,262 - $190,791	-4,300 Reduced 38.39%	6,900 $283,000
Q1 2024 May 15, 2024	BUY	$39.12 - $52.44 $242,543 - $325,128	6,200 Added 124.0%	11,200 $485,000
Q4 2023 Feb 14, 2024	SELL	$21.39 - $49.64 $387,159 - $898,484	-18,100 Reduced 78.35%	5,000 $229,000
Q3 2023 Nov 15, 2023	BUY	$15.81 - $27.8 $365,211 - $642,180	23,100 New	23,100 $529,000

191

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.15B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.